- Global Pharma News & Resources

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022, to stockholders of record as of the close of business on August 18, 2022.

About Labcorp

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 75,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $16 billion in FY2021. Learn more about Labcorp at or follow us on LinkedIn and Twitter @Labcorp.


Investors: Chas Cook - 336-436-5076

Media: Christopher Allman-Bradshaw - 336-436-8263

Editor Details

  • Company:
    • Businesswire
Last Updated: 14-Jul-2022